Adding throat lymphoid tissue removal to sinus surgery for nasal polyps
Compares sinus surgery with or without lymphoid tissue ablation in adults with nasal polyps.
Key facts
- Who runs it
- Tongji Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps
- Status
- Recruiting
- People taking part
- 32 people, planned
- Started
- 1 Jul 2025
- Planned end
- 1 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nasopharyngeal Lymphoid Tissue Ablation
- Full-House Endoscopic Sinus Surgery
- Record updated
- 24 November 2025
Who can take part
The trial is looking for adults with chronic sinus inflammation with nasal polyps (CRSwNP) who will have full-house endoscopic sinus surgery. Some will also have the lymph tissue at the back of the nose removed.
- Age
- 18 to 65 years
- Sex
- All sexes
- Disease stage
- Chronic rhinosinusitis with nasal polyps (CRSwNP), diagnosed by EPOS criteria
- Biomarker or test result
- Blood eosinophil count above 0.3 × 10⁹/L
- Main reasons for not taking part
- Pregnant or breastfeeding women
- Cystic fibrosis, primary ciliary dyskinesia, fungal ball sinus disease, systemic vasculitis or granulomatous disease
- Cancer or a weak immune system (immunodeficiency)
- Upper airway infection in the past 4 weeks
- Being in another clinical trial now or within 30 days
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Aged 18-65 years
- Diagnosed with CRSwNP according to EPOS criteria
- Blood eosinophil count > 0.3 × 10⁹/L
Who cannot take part
- systemic vasculitis or granulomatous disease
- malignancy
- Subjects with an upper-respiratory-tract infection within the past 4 weeks
- Clinically significant metabolic, cardiovascular, immune, neurologic, hematologic, gastrointestinal, cerebrovascular, or respiratory disorders, or any condition that, in the investigator's opinion, could interfere with outcome assessment or compromise patient safety
- Pregnant or lactating women
- Cystic fibrosis
- primary ciliary dyskinesia
- fungal ball rhinosinusitis
- immunodeficiency
- Currently participating in another clinical trial or having participated in one within 30 days, or staff directly involved in this study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Nasal polyps
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is designed to evaluate whether the addition of nasopharyngeal lymphoid tissue ablation to full-house endoscopic sinus surgery (ESS) provides superior control of nasal mucosa inflammation compared to full-house ESS alone in patients with nasal polyps. Thirty-two adult participants will be randomly assigned to undergo either full-house ESS only or full-house ESS combined with nasopharyngeal lymphoid tissue ablation. The primary outcome will be assessed through changes in inflammatory cell profiles at 1, 3, and 6 months postoperatively. Secondary outcomes include inflammatory cytokine levels, symptom scores, endoscopic findings, polyp recurrence rates, and safety measures.
The 2 groups in the trial
- Full-House Endoscopic Sinus Surgery Combined with Nasopharyngeal Lymphoid Tissue AblationTreatment being tested
Treatment: Nasopharyngeal Lymphoid Tissue Ablation and Full-House Endoscopic Sinus Surgery
- Full-House Endoscopic Sinus SurgeryExisting treatment, for comparison
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Full-House Endoscopic Sinus Surgery With Versus Without Nasopharyngeal Lymphoid Ablation on Local Mucosal Inflammation in Chronic Rhinosinusitis With Nasal Polyps
- Plain-language title
- Adding throat lymphoid tissue removal to sinus surgery for nasal polypsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07245329, who can take part
- Record updated
- 24 November 2025